EC Number   |
Substrates |
Organism |
Products |
Reversibility |
|---|
   3.4.21.75 | (2-Aminobenzoyl)-Lys-Glu-Arg-Ser-Lys-Arg-Ser-Ala-Leu-Arg-Asp-(3-nitro)Tyr-Ala + H2O |
- |
Homo sapiens |
(2-Aminobenzoyl)-Lys-Glu-Arg-Ser-Lys-Arg + Ser-Ala-Leu-Arg-Asp-(3-nitro)Tyr-Ala |
- |
? |
| 3.4.21.75 | 2-amino benzoyl-AEQDRNTREVFAQ-T(3-nitro-tyrosine)-A + H2O |
furin-mediated cleavage of a fluorogenic peptide derived from hSARS-CoV spike protein |
Homo sapiens |
2-amino benzoyl-AEQDRNTR + EVFAQ-T(3-nitro-tyrosine)-A |
- |
? |
| 3.4.21.75 | 2-aminobenzoyl-Arg-Val-Lys-Arg-Gly-Leu-Ala-Tyr(NO2)-Asp + H2O |
- |
Homo sapiens |
? |
- |
? |
| 3.4.21.75 | 2-Aminobenzoyl-Arg-Val-Lys-Arg-Gly-Leu-Ala-Tyr(NO2)-Asp-OH + H2O |
- |
Mammalia |
? |
- |
? |
| 3.4.21.75 | 5-carboxyfluorescein-Gln-Arg-Val-Arg-Arg-Ala-Val-Gly-Ile-Asp-Lys(5-carboxytetramethylrhodamine)-OH + H2O |
- |
Homo sapiens |
? |
- |
? |
| 3.4.21.75 | Abz-Arg-Val-Lys-Arg-Gly-Leu-Ala-Tyr(NO2)-Asp-OH + H2O |
- |
Homo sapiens |
? |
- |
? |
| 3.4.21.75 | Abz-GIRRKRSVSHQ-EDDnp + H2O |
- |
Homo sapiens |
Abz-GIRRKR + SVSHQ-EDDnp |
- |
? |
| 3.4.21.75 | Abz-GIRRKRSVSHQ-N-(2,4-dinitrophenyl)ethylenediamine + H2O |
FRET-peptide derived from Rous sarcoma viral envelope glycoprotein |
Homo sapiens |
Abz-GIRRKR + SVSHQ-N-(2,4-dinitrophenyl)ethylenediamine |
- |
? |
| 3.4.21.75 | Abz-GRRTRREAIVQ-N-(2,4-dinitrophenyl)ethylenediamine + H2O |
FRET-peptide derived from Ebola Zaire viral envelope glycoprotein |
Homo sapiens |
Abz-GRRTRR + EAIVQ-N-(2,4-dinitrophenyl)ethylenediamine |
- |
? |
| 3.4.21.75 | Abz-HHRQRRSVSIQ-N-(2,4-dinitrophenyl)ethylenediamine + H2O |
FRET-peptide derived from human A disintegrin and metalloproteinase with thrombospondin ADAM-TS 6 |
Homo sapiens |
Abz-HHRQRR + SVSIQ-N-(2,4-dinitrophenyl)ethylenediamine |
- |
? |
